RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Larimar Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-26 4:17 pm Purchase | 2024-02-16 | 13G | Larimar Therapeutics, Inc. LRMR | RA CAPITAL MANAGEMENT L.P. | 6,045,351 9.500% | 6,045,351 (New Position) | Filing |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Larimar Therapeutics, Inc. LRMR | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,334,610 (Position Closed) | Filing |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | RA CAPITAL MANAGEMENT L.P. | 1,334,610 7.500% | -180,541 (-11.92%) | Filing |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | RA CAPITAL MANAGEMENT L.P. | 1,515,151 9.900% | 1,515,151 (New Position) | Filing |